These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 31314511)
21. Efficient refolding and immobilization of PMMA-tag-fused single-chain Fv antibodies for sensitive immunological detection on a PMMA plate. Kumada Y; Ishikawa Y; Fujiwara Y; Takeda R; Miyamoto R; Niwa D; Momose S; Kang B; Kishimoto M J Immunol Methods; 2014 Sep; 411():1-10. PubMed ID: 24910412 [TBL] [Abstract][Full Text] [Related]
22. Refolding of Aggregation-Prone ScFv Antibody Fragments Assisted by Hydrophobically Modified Poly(sodium acrylate) Derivatives. Martin N; Costa N; Wien F; Winnik FM; Ortega C; Herbet A; Boquet D; Tribet C Macromol Biosci; 2017 Feb; 17(2):. PubMed ID: 27548824 [TBL] [Abstract][Full Text] [Related]
23. Equilibrium unfolding studies of monellin: the double-chain variant appears to be more stable than the single-chain variant. Aghera N; Earanna N; Udgaonkar JB Biochemistry; 2011 Apr; 50(13):2434-44. PubMed ID: 21351752 [TBL] [Abstract][Full Text] [Related]
24. Secretion from bacterial versus mammalian cells yields a recombinant scFv with variable folding properties. Vendel MC; Favis M; Snyder WB; Huang F; Capili AD; Dong J; Glaser SM; Miller BR; Demarest SJ Arch Biochem Biophys; 2012 Oct; 526(2):188-93. PubMed ID: 22230329 [TBL] [Abstract][Full Text] [Related]
25. Congenital Cataract-Causing Mutation G129C in γC-Crystallin Promotes the Accumulation of Two Distinct Unfolding Intermediates That Form Highly Toxic Aggregates. Xi YB; Chen XJ; Zhao WJ; Yan YB J Mol Biol; 2015 Aug; 427(17):2765-81. PubMed ID: 26165230 [TBL] [Abstract][Full Text] [Related]
26. VH/VL interface engineering to promote selective expression and inhibit conformational isomerization of thrombopoietin receptor agonist single-chain diabody. Igawa T; Tsunoda H; Kikuchi Y; Yoshida M; Tanaka M; Koga A; Sekimori Y; Orita T; Aso Y; Hattori K; Tsuchiya M Protein Eng Des Sel; 2010 Aug; 23(8):667-77. PubMed ID: 20576629 [TBL] [Abstract][Full Text] [Related]
27. A study on the effect of surface lysine to arginine mutagenesis on protein stability and structure using green fluorescent protein. Sokalingam S; Raghunathan G; Soundrarajan N; Lee SG PLoS One; 2012; 7(7):e40410. PubMed ID: 22792305 [TBL] [Abstract][Full Text] [Related]
28. ScFv Improvement Approaches. Bemani P; Mohammadi M; Hakakian A Protein Pept Lett; 2018; 25(3):222-229. PubMed ID: 29189116 [TBL] [Abstract][Full Text] [Related]
29. Disrupting the hydrophobic patches at the antibody variable/constant domain interface: improved in vivo folding and physical characterization of an engineered scFv fragment. Nieba L; Honegger A; Krebber C; Plückthun A Protein Eng; 1997 Apr; 10(4):435-44. PubMed ID: 9194169 [TBL] [Abstract][Full Text] [Related]
30. The interaction between residues 62 and 193 play a key role in activity and structural stability of arginine kinase. Liu N; Wang JS; Wang WD; Pan JC Int J Biol Macromol; 2011 Oct; 49(3):402-8. PubMed ID: 21645540 [TBL] [Abstract][Full Text] [Related]
31. Cloning and characterization of a single-chain fragment of monoclonal antibody to ACE suitable for lung endothelial targeting. Balyasnikova IV; Berestetskaya JV; Visintine DJ; Nesterovitch AB; Adamian L; Danilov SM Microvasc Res; 2010 Dec; 80(3):355-64. PubMed ID: 20888351 [TBL] [Abstract][Full Text] [Related]
32. Unravelling enhancement of antibody fragment stability - Role of format structure and cysteine modification. Ma H; Ó'Fágáin C; O'Kennedy R J Immunol Methods; 2019 Jan; 464():57-63. PubMed ID: 30468735 [TBL] [Abstract][Full Text] [Related]
33. Design and assessment of an active anti-epidermal growth factor receptor (EGFR) single chain variable fragment (ScFv) with improved solubility. Nautiyal K; Kibria MG; Akazawa-Ogawa Y; Hagihara Y; Kuroda Y Biochem Biophys Res Commun; 2019 Jan; 508(4):1043-1049. PubMed ID: 30551882 [TBL] [Abstract][Full Text] [Related]
34. An anti-Aβ (amyloid β) single-chain variable fragment prevents amyloid fibril formation and cytotoxicity by withdrawing Aβ oligomers from the amyloid pathway. Marín-Argany M; Rivera-Hernández G; Martí J; Villegas S Biochem J; 2011 Jul; 437(1):25-34. PubMed ID: 21501114 [TBL] [Abstract][Full Text] [Related]
35. Soluble expression of single-chain variable fragment (scFv) in Escherichia coli using superfolder green fluorescent protein as fusion partner. Liu M; Wang B; Wang F; Yang Z; Gao D; Zhang C; Ma L; Yu X Appl Microbiol Biotechnol; 2019 Aug; 103(15):6071-6079. PubMed ID: 31175428 [TBL] [Abstract][Full Text] [Related]
36. The Antibody Light-Chain Linker Is Important for Domain Stability and Amyloid Formation. Nokwe CN; Hora M; Zacharias M; Yagi H; John C; Reif B; Goto Y; Buchner J J Mol Biol; 2015 Nov; 427(22):3572-3586. PubMed ID: 26408269 [TBL] [Abstract][Full Text] [Related]
37. Biophysical analysis of three novel profilin-1 variants associated with amyotrophic lateral sclerosis indicates a correlation between their aggregation propensity and the structural features of their globular state. Del Poggetto E; Gori L; Chiti F Biol Chem; 2016 Sep; 397(9):927-37. PubMed ID: 27101547 [TBL] [Abstract][Full Text] [Related]
38. Mapping the Aggregation Kinetics of a Therapeutic Antibody Fragment. Chakroun N; Hilton D; Ahmad SS; Platt GW; Dalby PA Mol Pharm; 2016 Feb; 13(2):307-19. PubMed ID: 26692229 [TBL] [Abstract][Full Text] [Related]
39. Partial unfolding of a monoclonal antibody: role of a single domain in driving protein aggregation. Mehta SB; Bee JS; Randolph TW; Carpenter JF Biochemistry; 2014 May; 53(20):3367-77. PubMed ID: 24804773 [TBL] [Abstract][Full Text] [Related]
40. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency. Tan PH; Sandmaier BM; Stayton PS Biophys J; 1998 Sep; 75(3):1473-82. PubMed ID: 9726949 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]